NVNO
HealthcareenVVeno Medical Corporation
Live · NASDAQ · May 9, Close
What's Moving NVNO Today?
No stock-specific AI insight has been generated for NVNO yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
NVNO News
20 articles- enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe SystemYahoo Finance·May 7, 2026
- One enVVeno Medical Insider Raised Their Stake In The Previous YearYahoo Finance·May 6, 2026
- enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous ValveYahoo Finance·Apr 29, 2026
- enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) SystemYahoo Finance·Mar 27, 2026
- NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic AlternativesYahoo Finance·Mar 3, 2026
- enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price RequirementYahoo Finance·Feb 4, 2026
- enVVeno Medical Announces Reverse Stock SplitYahoo Finance·Jan 15, 2026
- enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect SegmentYahoo Finance·Nov 26, 2025
- Insider Buyers Lose Additional US$294k As enVVeno Medical Dips To US$6.5mYahoo Finance·Nov 22, 2025
- enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValveYahoo Finance·Nov 13, 2025
- enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate UpdateYahoo Finance·Oct 31, 2025
- enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" SegmentYahoo Finance·Sep 26, 2025
- enVVeno Medical Updates Regulatory Status of VenoValve(R)Yahoo Finance·Sep 15, 2025
- NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValveYahoo Finance·Aug 25, 2025
- Sector Update: Health Care Stocks Advance Late AfternoonYahoo Finance·Aug 20, 2025
- EnVVeno Medical Gets FDA Not-Approvable Letter for VenoValve; Shares Fall 70%Yahoo Finance·Aug 20, 2025
- enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R)Yahoo Finance·Aug 20, 2025
- JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025Yahoo Finance·Aug 15, 2025
- enVVeno Medical to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTechYahoo Finance·Aug 15, 2025
- Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous InsufficiencyYahoo Finance·Aug 6, 2025
All 20 articles loaded
Price Data
Fundamentals
Trading
About enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.